ISSARA (ISSARA) Fair Value & Analysis
· Market cap 662M THB
Fair value as of: Jun 24, 2026
From 20 valuation models · updated 9 days ago
Fair value updated Jun 24, 2026 — revised from 7.21 THB to 8.44 THB (+17.1%) since Jun 23, 2026. Share price −1.5% over the past month.
Price vs Fair Value (12 months)
12‑month range 5.71 THB – 7.62 THB · fair‑value band 5.91 THB – 9.74 THB · the 6.55 THB price screens below the 8.44 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
ISSARA (ISSARA) currently trades at 6.55 THB, while our model-based Fair Value estimate is 8.44 THB — implying the stock looks roughly 28.9% undervalued today. We read business quality at 64/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
The stock trades on a trailing P/E of 13.4. Fundamentals as of Jun 24, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2020 – FY2023 · reported fiscal years
ISSARA reported revenue of 110M THB in FY2023 versus 125M THB in FY2020, a compound −4.3%/yr. Reported net income was 55.7M THB in FY2023, compounding −6.6%/yr from FY2020.
Is ISSARA fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is ISSARA (ISSARA) undervalued?
What is the fair value of ISSARA?
What is the quality score of ISSARA?
What is the net profit margin of ISSARA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.